InvestorsHub Logo
Followers 800
Posts 50879
Boards Moderated 2
Alias Born 12/12/2004

Re: screamingeagle post# 27419

Wednesday, 01/09/2008 1:09:29 PM

Wednesday, January 09, 2008 1:09:29 PM

Post# of 35781
Today is an excellent buying opportunity:

Fiscal Year 2008 Outlook

IDGLOBAL’s business model of delivering and showcasing its Nano-Molecular Markers™ for Anti-Counterfeiting and IDFORENSIX™ for Anti-Theft/loss prevention products will continue through an aggressive tradeshow and conference schedule throughout the 2008 fiscal year. Revenues and the roster of clients for its Nano-Molecular Markers™ has grown significantly in fiscal year 2007 and IDGLOBAL is engaged in multiple pilot projects, proposals and early stage discussions with a number of Fortune 100 companies. IDGLOBAL has been receiving client inquiries and requests for demonstrations and pilot project testing for its Nano-Molecular Anti-Counterfeiting Solutions at a significant pace as a direct result of its strategy associated with demonstrating its products at high-profile events and tradeshows. IDGLOBAL shall release information regarding any material developments as they become available.

Beginning IDGLOBAL’s second full year of operation, IDGLOBAL anticipates a break-even financial condition for 2008. This can be augmented to a polarity given multiple successful client acquisitions; however, IDGLOBAL Management prefers a conservative opinion in providing the markets with forward-looking financial information.

January 2008 Corporate Update

In January 2008, IDGLOBAL will be engaging in multiple client meetings, discussions and advancing opportunities associated with recent meetings with high-level Barristers/Lawyers and some of Silicon Valley’s largest organizations that include Apparel, Garment and Technical Corporations as well as specific discussions in the Pharmaceutical verticals.

Also in January, IDGLOBAL will begin working directly with its partner, ATL Pharma Security Label Systems™ (www.atlco.com), a division of Ad Tape & Label Co, in directly marketing IDGLOBAL’S Nano-Molecular Markers™ to ATL’s list of Pharmaceutical clients which include some of the largest Pharmaceutical companies in that vertical. IDGLOBAL secured an unprecedented ten (10)-year contract to supply its Nano-Molecular Marking™, anti-counterfeiting technology to ATL Pharma Security Label Systems™ as announced back on July 24, 2007 and December 4, 2007.

ATL is one of the world’s leading secure label solutions providers, manufacturing more than half of all pharmaceutical clinical trial labels for most of the major Pharmaceutical corporations. In the past 7 years ATL has produced more than 120 million pharmaceutical labels (including 19 page booklets), in over 80 languages, for over 1,700 clinical trials. In business since 1951, ATL is an FDA Registered Medical Device manufacturer that also specializes in “private brand” disposable medical device manufacturing. See attached link Pharmaceutical Counterfeiting for more information: http://www.atlco.com/medical/PharmaAntiCounterfeiting.html




To be is to do.(Socrates) To do is to be.(Plato) Do be do be do!!!!!(Sinatra)

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.